MDT

86.26

-0.61%↓

118.39

-1.65%↓

VEEV

167.79

+0.74%↑

HQY

85.02

+3.41%↑

NEOG

9.24

-2.22%↓

MDT

86.26

-0.61%↓

118.39

-1.65%↓

VEEV

167.79

+0.74%↑

HQY

85.02

+3.41%↑

NEOG

9.24

-2.22%↓

MDT

86.26

-0.61%↓

118.39

-1.65%↓

VEEV

167.79

+0.74%↑

HQY

85.02

+3.41%↑

NEOG

9.24

-2.22%↓

MDT

86.26

-0.61%↓

118.39

-1.65%↓

VEEV

167.79

+0.74%↑

HQY

85.02

+3.41%↑

NEOG

9.24

-2.22%↓

MDT

86.26

-0.61%↓

118.39

-1.65%↓

VEEV

167.79

+0.74%↑

HQY

85.02

+3.41%↑

NEOG

9.24

-2.22%↓

Home・Akcijų sąrašas・Pulse Biosciences Inc

Pulse Biosciences Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

20.28 4.75

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

19.35

Max

20.53

Pagrindiniai rodikliai
By Trading Economics
Pajamos	2M -17M
Pardavimai	178K 264K
Pelnas, tenkantis vienai akcijai	-0.18
Pelno marža	-6,603.409
Darbuotojai	116
EBITDA	2M -17M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+52.75% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-05-07

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	328M 1.3B
Ankstesnė atidarymo kaina	15.53
Ankstesnė uždarymo kaina	20.28

Naujienos nuotaikos

By Acuity

21%

79%

52 / 348 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

16.59 / 17.17 Palaikymas ir pasipriešinimas

Pulse Biosciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-04-15 23:14; UTC

Uždarbis

Battery Maker CATL First-Quarter Net Rose on Strong Demand

2026-04-15 23:14; UTC

Uždarbis

Battery Maker CATL First Quarter Net Rose On Strong Demand

2026-04-15 17:13; UTC

Pagrindinės rinkos jėgos

Tesla Shares Rise on Completion of AI5 Chip Design Process

2026-04-15 23:39; UTC

Rinkos pokalbiai

Nikkei May Rise After Gains on Wall Street -- Market Talk

2026-04-15 23:35; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Gold Rises Amid Hopes for More U.S.-Iran Talks -- Market Talk

2026-04-15 22:41; UTC

Uždarbis

CATL 1Q Net CNY20.74 Vs. Net CNY13.96B >300750.SZ

2026-04-15 22:38; UTC

Uždarbis

CATL 1Q Rev CNY129.13B Vs. CNY84.70B >300750.SZ

2026-04-15 22:15; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-04-15 22:15; UTC

Rinkos pokalbiai

J.B. Hunt Flag Fundamental Shift in 1Q -- Market Talk

2026-04-15 22:14; UTC

Uždarbis

Lens Technology Results Weighed by Lower Rev From Smartphone, Computer Business >300433.SZ

2026-04-15 22:12; UTC

Uždarbis

Lens Technology 1Q Oper Income CNY14.14B Vs. CNY17.06B>300433.SZ

2026-04-15 22:11; UTC

Uždarbis

Lens Technology 1Q Loss CNY149.60M Vs. Net CNY428.88M >300433.SZ

2026-04-15 22:11; UTC

Uždarbis

Lens Technology Swings to Loss in 1Q>300433.SZ

2026-04-15 22:07; UTC

Uždarbis

Big Bank Earnings Show Consumers Are on Solid Ground -- Against All Odds -- Barrons.com

2026-04-15 21:34; UTC

Įsigijimai, susijungimai, perėmimai

Skild AI Acquires Zebra Technologies' Robotics Automation Business

2026-04-15 21:29; UTC

Karštos akcijos

Stocks to Watch: Bank of America, Live Nation, Snap, Hermès -- WSJ

2026-04-15 20:50; UTC

Rinkos pokalbiai

Uždarbis

Financial Services Roundup: Market Talk

2026-04-15 20:30; UTC

Uždarbis

PepsiCo Cuts Prices, Revamps Products. Earnings Will Show if It's Working. -- Barrons.com

2026-04-15 20:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2026-04-15 20:06; UTC

Rinkos pokalbiai

Silver Inches Up as Attention Turns to World Deficit -- Market Talk

2026-04-15 19:46; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

Jamie Dimon Says JPMorgan Stock Isn't Cheap. Why the Bank Is Still Buying Back Billions. -- Barrons.com

2026-04-15 19:25; UTC

Rinkos pokalbiai

Automakers' 1Q Earnings Could Give Clues to EV Comeback -- Market Talk

2026-04-15 19:00; UTC

Rinkos pokalbiai

U.S. Natural Gas Edges Up Ahead of Storage Data -- Market Talk

2026-04-15 18:58; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Settles Flat As Market Awaits Conflict Developments -- Market Talk

2026-04-15 18:11; UTC

Įsigijimai, susijungimai, perėmimai

Three Lessons From Amazon's Blockbuster Deal to Buy Globalstar -- Barrons.com

2026-04-15 17:45; UTC

Įsigijimai, susijungimai, perėmimai

Apple CEO Tim Cook Buys Nike Stock. His Last Purchase Didn't Go So Well. -- Barrons.com

2026-04-15 16:58; UTC

Uždarbis

Bank of America's Wealth Management Profits Rise Amid 'Resilient' U.S. Economy -- Barrons.com

2026-04-15 16:52; UTC

Uždarbis

Snap and Other Companies Blame AI for Layoffs. Is It Just a Convenient Excuse? -- Barrons.com

2026-04-15 16:46; UTC

Rinkos pokalbiai

Svarbiausios naujienos

U.S. Crude Oil Stocks Finally See Drawdowns -- Market Talk

2026-04-15 16:37; UTC

Rinkos pokalbiai

Uždarbis

Global Equities Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Pulse Biosciences Inc Prognozė

Kainos tikslas

By TipRanks

52.75% į viršų

12 mėnesių prognozė

Vidutinis 30 USD 52.75%

Aukščiausias 30 USD

Žemiausias 30 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Pulse Biosciences Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

Pirkti

Laikyti

Parduoti

Remiantis 2 analitikų, pateikusių Pulse Biosciences Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

16.59 / 17.17Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

Rinkos nuotaikos

By Acuity

52 / 348 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.